Published in Clin Immunol on June 01, 2001
Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A (2004) 3.57
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol (2009) 2.17
Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis (2008) 1.78
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol (2007) 1.72
In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus. Hepatology (2011) 1.23
Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev (2003) 1.13
Neutralizing antibodies in hepatitis C virus infection. World J Gastroenterol (2007) 0.95
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections. PLoS One (2011) 0.91
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis (2012) 0.88
Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy. Front Biosci (Landmark Ed) (2009) 0.86
Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats. Virol J (2009) 0.86
Glances in Immunology of HIV and HCV Infection. Adv Virol (2012) 0.82
Human normal immunoglobulin in the treatment of primary immunodeficiency diseases. Ther Clin Risk Manag (2012) 0.79
Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C. World J Gastroenterol (2008) 0.78
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. World J Gastroenterol (2014) 0.76
Treatment of HCV infection with interferon alpha-2b and ribavirin in a patient with X-linked lymphoproliferative syndrome. Eur J Pediatr (2006) 0.75
Recurrent and Sustained Viral Infections in Primary Immunodeficiencies. Front Immunol (2017) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Photochemical and mutational analysis of the FMN-binding domains of the plant blue light receptor, phototropin. Biochemistry (2000) 4.47
Arabidopsis nph1 and npl1: blue light receptors that mediate both phototropism and chloroplast relocation. Proc Natl Acad Sci U S A (2001) 4.16
Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet (1995) 4.12
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
The photocycle of a flavin-binding domain of the blue light photoreceptor phototropin. J Biol Chem (2001) 2.90
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Cap polyposis--an unusual cause of diarrhoea. Gut (1993) 2.38
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
The phototropin family of photoreceptors. Plant Cell (2001) 2.01
Arabidopsis contains at least four independent blue-light-activated signal transduction pathways. Plant Physiol (1999) 1.94
Models of mitochondrial DNA transmission genetics and evolution in higher eucaryotes. Genet Res (1982) 1.89
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1989) 1.69
Characterization of a murine model of allergic pulmonary inflammation. Int Arch Allergy Immunol (1994) 1.66
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
The hospitalist: implications for family practice. Fam Med (1998) 1.59
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
Increased prevalence of Listeria monocytogenes in the faeces of patients receiving long-term H2-antagonists. Eur J Gastroenterol Hepatol (1996) 1.52
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut (1986) 1.49
Role of CXCR2 in cigarette smoke-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol (2005) 1.49
Identification of UV/blue light-response elements in the Arabidopsis thaliana chalcone synthase promoter using a homologous protoplast transient expression system. Plant Mol Biol (1998) 1.47
Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease. Inflamm Bowel Dis (2001) 1.44
Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med (1995) 1.40
Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res (2001) 1.38
Absorption of starch by healthy ileostomates: effect of transit time and of carbohydrate load. Am J Clin Nutr (1985) 1.38
Immune gene discovery by expressed sequence tag analysis of hemocytes and hepatopancreas in the Pacific White Shrimp, Litopenaeus vannamei, and the Atlantic White Shrimp, L. setiferus. Dev Comp Immunol (2001) 1.34
Accuracy of computed tomography in diagnosis of fatty liver. Br Med J (1980) 1.32
Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol (1995) 1.32
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. Gastroenterology (2001) 1.31
Ulcerative colitis and persistent liver dysfunction. Q J Med (1983) 1.27
Computed tomography for determining liver iron content in primary haemochromatosis. Br Med J (1980) 1.25
Raised gamma-glutamyltransferase activity and the need for liver biopsy. BMJ (1991) 1.23
Phototropins: a new family of flavin-binding blue light receptors in plants. Antioxid Redox Signal (2001) 1.22
Antitussive effects of GABAB agonists in the cat and guinea-pig. Br J Pharmacol (1993) 1.22
Habitat, applications and genomics of the aerobic, thermophilic genus Geobacillus. Biochem Soc Trans (2004) 1.21
Influence of central antitussive drugs on the cough motor pattern. J Appl Physiol (1985) (1999) 1.21
Increased prevalence of epilepsy in coeliac disease. Br Med J (1978) 1.20
Carcinoid tumour of the ampulla of Vater presenting as acute pancreatitis. Gut (1987) 1.20
Diclofenac associated hepatitis. J Hepatol (1990) 1.18
Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol (1995) 1.18
Tachykinin NK3-receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice. Pharmacol Res (2004) 1.17
Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol (2001) 1.16
Occurrence of trans-ribosylzeatin in Agrobacterium tumefaciens tRNA. Nature (1976) 1.14
Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload. J Clin Pathol (1982) 1.14
Early postoperative endoscopic sphincterotomy for retained biliary stones. Ann R Coll Surg Engl (1988) 1.12
Peripheral and central sites of action of GABA-B agonists to inhibit the cough reflex in the cat and guinea pig. Br J Pharmacol (1994) 1.11
Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up. Clin Exp Immunol (1997) 1.11
HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology (1994) 1.10
Long-standing asymptomatic primary sclerosing cholangitis: report of three cases. Dig Dis Sci (1981) 1.08
Failure to keep clinic appointments: implications for residency education and productivity. Fam Med (1999) 1.07
Role of biliary stenting in the management of bile duct stones in the elderly. Gut (1995) 1.06
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut (2002) 1.05
Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC. Aliment Pharmacol Ther (2015) 1.05
Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci (1982) 1.04
Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol (1997) 1.04
Modern management of oesophageal varices. Postgrad Med J (2001) 1.03
Misuse of ecstasy. BMJ (1992) 1.00
Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut (1992) 0.99
Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol (1985) (1999) 0.98
Effects of graded reduction of brain blood flow on chemical control of breathing. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.98
Effect of Sch 55700, a humanized monoclonal antibody to human interleukin-5, on eosinophilic responses and bronchial hyperreactivity. Arzneimittelforschung (1999) 0.97
Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol (1999) 0.97
Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut (2001) 0.95
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther (2007) 0.95
Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology (1994) 0.95
Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin). J Hepatol (1995) 0.94
Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus. Hepatology (1999) 0.94
Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther (1996) 0.94
Ruthenium red decreases capsaicin and citric acid-induced cough in guinea pigs. Neurosci Lett (1991) 0.94
Review article: current management of primary sclerosing cholangitis. Aliment Pharmacol Ther (2005) 0.93
Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther (1999) 0.92
Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Aliment Pharmacol Ther (2011) 0.92
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut (2002) 0.92
Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1996) 0.92
Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines. Br J Pharmacol (2000) 0.91
Computed tomography attenuation values in fatty liver. J Comput Tomogr (1981) 0.90
EcoGenomics--a consilience for comparative immunology? Dev Comp Immunol (2001) 0.90
Effect of propranolol on pulmonary function and bronchoconstrictor responsiveness in guinea pigs and rats. Pharmacol Res Commun (1985) 0.90
Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis. J Hepatol (1989) 0.90
A transcriptomic analysis of the stress induced by capture-release health assessment studies in wild dolphins (Tursiops truncatus). Mol Ecol (2008) 0.90
Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology (1996) 0.89
The pharmacology of SCH 50911: a novel, orally-active GABA-beta receptor antagonist. J Pharmacol Exp Ther (1995) 0.89
Acute hepatitis C infection after sexual exposure. Gut (1995) 0.89
Biology of interleukin-5 and its relevance to allergic disease. Allergy (1996) 0.89
Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am J Respir Cell Mol Biol (1998) 0.89
Liver transplantation for primary sclerosing cholangitis. Liver (2000) 0.88
Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol (2004) 0.88
Histological features of sclerosing cholangitis in patients with chronic ulcerative colitis. J Clin Pathol (1985) 0.88
Central nervous system control of airway tone in guinea pigs: the role of histamine. J Appl Physiol (1985) (1988) 0.88
PSC, AIH and overlap syndrome in inflammatory bowel disease. Clin Res Hepatol Gastroenterol (2012) 0.87
Pharmacological studies of allergic cough in the guinea pig. Eur J Pharmacol (1995) 0.87
Primary sclerosing cholangitis--an immunologically mediated disease? West J Med (1985) 0.86
Inhibition of sympathetic hypertensive responses in the guinea-pig by prejunctional histamine H3-receptors. Br J Pharmacol (1992) 0.86
Mechanisms of allergic pulmonary eosinophilia in the mouse. J Allergy Clin Immunol (1994) 0.86
Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury. Ann Pharmacother (1996) 0.86
(R)-alpha-methylhistamine augments neural, cholinergic bronchospasm in guinea pigs by histamine H1 receptor activation. Eur J Pharmacol (1992) 0.86